150 related articles for article (PubMed ID: 23313278)
1. The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review.
Zhang X; Fu S; Han S; Zheng X; Wang L
Transpl Immunol; 2013 Mar; 28(2-3):106-11. PubMed ID: 23313278
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
Xing S; Yang J; Zhang X; Zhou P
Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Mizoribine Combined With Tacrolimus in Living Donor Kidney Transplant Recipients: 3-Year Results by a Chinese Single Center Study.
Shi Y; Liu H; Chen XG; Shen ZY
Transplant Proc; 2019 Jun; 51(5):1337-1342. PubMed ID: 31155174
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.
Chen J; Liu H; Yin W; Xu Z; Chen Z; Yiu W
Comput Intell Neurosci; 2022; 2022():5717068. PubMed ID: 35909831
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
Ushigome H; Uchida K; Nishimura K; Akioka K; Fukuda Y; Yuzawa K; Fujisawa M; Sugitani A; Ito SI; Nakatani T; Horimi T; Yoshimura N
Transplant Proc; 2016 Apr; 48(3):794-8. PubMed ID: 27234738
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of a Quadruple Regimen Compared with Triple Regimens in Patients with Mycophenolic Acid-Related Gastrointestinal Complications After Renal Transplantation: A Short-Term Single-Center Study.
Peng Z; Xian W; Sun H; Li E; Geng L; Tian J
Ann Transplant; 2020 Feb; 25():e919875. PubMed ID: 32107364
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.
Yoshimura N; Ushigome H; Akioka K; Nobori S; Suzuki T; Sakai K; Okamoto M
Clin Exp Nephrol; 2013 Feb; 17(1):127-33. PubMed ID: 23011290
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation.
Huang Y; Han M; Yang D; Zhang R; Ma Q; Pang A; Zhai W; He Y; Wei J; Jiang E; Feng S; Zhang L
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1663-1669. PubMed ID: 32504862
[TBL] [Abstract][Full Text] [Related]
11. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
Knight SR; Russell NK; Barcena L; Morris PJ
Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
14. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.
Hong T; Zhang M; Fan J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
Shi Y; Liu H; Chen XG; Shen ZY
Transplant Proc; 2017; 49(1):26-31. PubMed ID: 28104150
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
17. Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.
Ding X; Zhu X; Zhang Y; Zhang L; Cheng M; Yu Y; Xu L; Li G
Transplant Proc; 2013; 45(1):190-3. PubMed ID: 23375297
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
Takahara S; Takahashi K; Akiyama T; Uchida K; Tanabe K; Amada N; Toma H
Clin Exp Nephrol; 2013 Dec; 17(6):899-904. PubMed ID: 23430390
[TBL] [Abstract][Full Text] [Related]
19. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
[TBL] [Abstract][Full Text] [Related]
20. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
